Galderma receives US FDA approval for Restylane Contour for the correction of temple hollowing: Zug, Switzerland Tuesday, March 24, 2026, 18:00 Hrs [IST] Galderma, the pure-play d ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results